Eli Lilly & Co.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-204.1M | $2.74B | $2.41B | $2.39B | $4.68B | $4.09B | $4.35B | $5.07B |
| Depreciation & Amortization | $1.57B | $1.50B | $1.43B | $1.38B | $1.45B | $1.46B | $1.37B | $1.33B |
| Depreciation | $681.7M | $716.2M | $717.6M | $759.1M | $774.8M | $754.0M | $732.4M | $749.1M |
| Amortization | $462.2M | $687.9M | $631.8M | $535.9M | $555.0M | $563.0M | $469.0M | $385.7M |
| Stock-Based Compensation | $281.3M | $255.3M | $217.8M | $156.0M | $144.9M | $141.5M | $147.4M | $231.0M |
| Net Cash from Operating Activities | $5.62B | $4.85B | $2.96B | $4.46B | $5.74B | $5.30B | $7.23B | $6.86B |
| Investing Activities | ||||||||
| Capital Expenditures | $1.08B | $1.04B | $1.07B | $1.16B | $1.01B | $905.4M | $672.0M | $694.3M |
| Business Acquisitions | $882.1M | $45.0M | $5.28B | $551.4M | $43.7M | $199.3M | $307.8M | $609.4M |
| Net Cash from Investing Activities | $-3.78B | $-3.14B | $26.8M | $-3.91B | $-2.07B | $-2.83B | $-4.82B | $-3.16B |
| Financing Activities | ||||||||
| Dividends Paid | $2.19B | $2.16B | $2.13B | $2.10B | $2.12B | $2.19B | $2.18B | $2.17B |
| Stock Repurchases | $299.8M | $600.1M | $749.5M | $800.0M | $1.70B | $721.1M | $0 | $0 |
| Net Cash from Financing Activities | $142.6M | $-559.8M | $-3.11B | $-166.4M | $-3.83B | $-4.42B | $-2.37B | $-2.02B |
| Net Change in Cash | $1.95B | $915.7M | $-205.2M | $41.4M | $-188.6M | $-1.90B | $-70.7M | $1.53B |
| Free Cash Flow | $4.54B | $3.81B | $1.90B | $3.30B | $4.72B | $4.40B | $6.56B | $6.16B |